Latest filings (excl ownership)
10-K
2023 FY
Annual report
1 Apr 24
8-K
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
1 Apr 24
8-K
Entry into a Material Definitive Agreement
4 Mar 24
8-K
Termination of a Material Definitive Agreement
8 Feb 24
8-K
Departure of Directors or Certain Officers
17 Jan 24
8-K
Departure of Directors or Certain Officers
11 Jan 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Entry into a Material Definitive Agreement
9 Nov 23
8-K
Acutus Medical Reports Third Quarter 2023 Financial Results
8 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
30 Oct 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Acutus Medical Reports Second Quarter 2023 Financial Results
7 Aug 23
8-K
Departure of Directors or Certain Officers
5 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 23
SD
Conflict minerals disclosure
26 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Acutus Medical Reports First Quarter 2023 Financial Results
11 May 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
8-K
Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results
20 Apr 23
S-8
Registration of securities for employees
23 Mar 23
10-K
2022 FY
Annual report
23 Mar 23
8-K
Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
16 Mar 23
8-K
Other Events
13 Mar 23
8-K
Other Events
10 Jan 23
8-K
Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer
9 Jan 23
EFFECT
Notice of effectiveness
22 Dec 22
424B5
Prospectus supplement for primary offering
21 Dec 22
CORRESP
Correspondence with SEC
19 Dec 22
UPLOAD
Letter from SEC
16 Dec 22
S-3
Shelf registration
9 Dec 22
8-K
Entry into a Material Definitive Agreement
5 Dec 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Acutus Medical Reports Third Quarter 2022 Financial Results
10 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 Nov 22
8-K
Acutus Medical Achieves OEM Qualification Milestone in Sale of Left-Heart Access Portfolio to Medtronic
3 Nov 22
8-K
Departure of Directors or Certain Officers
22 Aug 22
EFFECT
Notice of effectiveness
22 Aug 22
Latest ownership filings
144
Notice of proposed sale of securities
4 Apr 24
4
Takeo Mukai
4 Mar 24
4
Tom Sohn
7 Feb 24
4
Takeo Mukai
2 Feb 24
4
Tom Sohn
2 Feb 24
4
Kevin Mathews
18 Jan 24
4
David Roman
18 Jan 24
SC 13D/A
Flynn James E
13 Nov 23
4
Takeo Mukai
5 Sep 23
4
Tom Sohn
7 Aug 23
4
Kevin Mathews
7 Aug 23
4
Tom Sohn
2 Aug 23
4
David Roman
2 Aug 23
4
Takeo Mukai
2 Aug 23
4/A
Andrew ElBardissi
29 Jun 23
4
James E Flynn
20 Jun 23
4
Shaden Marzouk
15 Jun 23
4
John F Sheridan
15 Jun 23
4
David P Bonita
15 Jun 23
4
R Scott Huennekens
15 Jun 23
4
Andrew ElBardissi
15 Jun 23
4
Jason K Garland
15 Jun 23
4
Niamh Louise Pellegrini
15 Jun 23
4
David Roman
1 Jun 23
4
Kevin Mathews
4 Apr 23
4
David Roman
4 Apr 23
4
Charlie Piscitello
4 Apr 23
4
Tom Sohn
4 Apr 23
4
Tom Sohn
2 Mar 23
4
Kevin Mathews
2 Mar 23
4
David Roman
2 Mar 23
4
Takeo Mukai
2 Mar 23
4
Charlie Piscitello
2 Mar 23
SC 13G/A
Capital World Investors
13 Feb 23
4
Takeo Mukai
2 Feb 23
4
David Roman
2 Feb 23
4
Charlie Piscitello
2 Feb 23
4
Kevin Mathews
2 Feb 23
4
Tom Sohn
2 Feb 23
4
R Scott Huennekens
11 Oct 22